相关实验视频
Updated: Jun 12, 2025
09:29
Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
Published on: January 9, 2015
15.4K
强迫症的最小重要差异:对成人双盲SSRI试验的分析
Sem E Cohen1,2, Jasper B Zantvoord1,2, Taina K Mattila3
1Department of Psychiatry, Amsterdam UMC, Amsterdam, The Netherlands.
概括
这项研究确定了强迫症症状变化的最小重要差异 (MID),使用耶鲁-布朗强迫症尺度 (YBOCS) 定义了临床相关的改善值. 这为评估强迫症治疗提供了一个基准.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
- 神经科学是一个神经科学.
背景情况:
- 强迫症障碍 (OCD) 中临床显著的症状变化的门仍然没有定义.
- 确定最小重要的差异 (MID) 对于解释强迫症治疗疗效至关重要.
研究的目的:
- 在成年强迫症患者中开发一种经验验证的临床意义值 (MID).
- 为了将耶鲁-布朗强迫症度表 (YBOCS) 的变化与临床全球印象 (CGI) 度表联系起来.
主要方法:
- 对1216名成年强迫症患者中选择性血清素再吸收抑制剂的7项安慰剂控制试验的个人参与者数据的分析.
- 从基线到12周,用于关联CGI和YBOCS得分的变化.
- MID定义为YBOCS变化,对应于CGI改进得分为3 ("最小改进").
主要成果:
- 在CGI和YBOCS分数之间观察到中等到高的相关性.
- 确定MID是YBOCS下降4.9个点 (比基线下降24%),95%的CI为4.4-5.4.4.
- 根据基线症状严重程度,MID有所变化,在较轻的病例中较低,在严重的病例中较高.
结论:
- 这项研究是第一个通过将YBOCS与CGI-Improvement (CGI-I) 联系来提出强迫症试验的MID.
- 一个定义的MID将有助于指导未来的临床研究和解释强迫症干预措施的有效性.
- 虽然基于临床医生,但需要进一步研究,将患者报告的结果作为YBOCS的点.
相关概念视频
02:07Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
01:28Obsessive-Compulsive Disorder
64
Obsessive-compulsive disorder (OCD) is a mental health condition characterized by recurrent obsessions, compulsions, or both, which consume significant time and interfere with daily functioning. Obsessions involve persistent, intrusive, and unwanted thoughts, images, or urges that evoke anxiety. Common examples include irrational fears of contamination or harm. Compulsions are repetitive behaviors or mental acts performed to reduce the anxiety caused by obsessions. For instance, individuals...
64
01:23Antidepressant Drugs: MAOIs and Other Agents
201
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
201
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
329
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
329
01:54The Placebo Effect
6.1K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.1K
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
103
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
103